Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.41
WMGI's Cash to Debt is ranked lower than
79% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. WMGI: 0.41 )
Ranked among companies with meaningful Cash to Debt only.
WMGI' s Cash to Debt Range Over the Past 10 Years
Min: 0.18  Med: 0.76 Max: N/A
Current: 0.41
Equity to Asset 0.32
WMGI's Equity to Asset is ranked lower than
83% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. WMGI: 0.32 )
Ranked among companies with meaningful Equity to Asset only.
WMGI' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.7 Max: 0.79
Current: 0.32
0.31
0.79
F-Score: 2
Z-Score: 0.52
M-Score: -2.35
WACC vs ROIC
8.20%
-14.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -26.79
WMGI's Operating margin (%) is ranked lower than
68% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. WMGI: -26.79 )
Ranked among companies with meaningful Operating margin (%) only.
WMGI' s Operating margin (%) Range Over the Past 10 Years
Min: -116.46  Med: -14.25 Max: -2.74
Current: -26.79
-116.46
-2.74
Net-margin (%) -71.90
WMGI's Net-margin (%) is ranked lower than
74% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. WMGI: -71.90 )
Ranked among companies with meaningful Net-margin (%) only.
WMGI' s Net-margin (%) Range Over the Past 10 Years
Min: -113.05  Med: -22.86 Max: -7.84
Current: -71.9
-113.05
-7.84
ROE (%) -60.09
WMGI's ROE (%) is ranked lower than
81% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. WMGI: -60.09 )
Ranked among companies with meaningful ROE (%) only.
WMGI' s ROE (%) Range Over the Past 10 Years
Min: -64.55  Med: -20.18 Max: -5.19
Current: -60.09
-64.55
-5.19
ROA (%) -26.70
WMGI's ROA (%) is ranked lower than
70% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 0.07 vs. WMGI: -26.70 )
Ranked among companies with meaningful ROA (%) only.
WMGI' s ROA (%) Range Over the Past 10 Years
Min: -40.3  Med: -9.33 Max: -3.73
Current: -26.7
-40.3
-3.73
ROC (Joel Greenblatt) (%) -58.39
WMGI's ROC (Joel Greenblatt) (%) is ranked lower than
64% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. WMGI: -58.39 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WMGI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -197.56  Med: -32.58 Max: -18
Current: -58.39
-197.56
-18
Revenue Growth (3Y)(%) -2.50
WMGI's Revenue Growth (3Y)(%) is ranked lower than
70% of the 224 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. WMGI: -2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WMGI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -14.9  Med: -5.3 Max: -2.5
Current: -2.5
-14.9
-2.5
EPS Growth (3Y)(%) 89.60
WMGI's EPS Growth (3Y)(%) is ranked higher than
93% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. WMGI: 89.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WMGI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -38.1  Med: 60 Max: 89.6
Current: 89.6
-38.1
89.6
GuruFocus has detected 6 Warning Signs with Wright Medical Group NV $WMGI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» WMGI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

WMGI Guru Trades in Q1 2016

Mario Gabelli 217,519 sh (New)
Jim Simons 332,478 sh (+55.36%)
Steven Cohen 1,816,100 sh (+42.67%)
Eaton Vance Worldwide Health Sciences Fund 1,855,647 sh (unchged)
Columbia Wanger Sold Out
Ken Fisher 2,329,797 sh (-1.21%)
Keeley Asset Management Corp 1,536,699 sh (-15.26%)
» More
Q2 2016

WMGI Guru Trades in Q2 2016

Ken Fisher 2,445,110 sh (+4.95%)
Mario Gabelli 217,519 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund Sold Out
Keeley Asset Management Corp 1,524,987 sh (-0.76%)
Steven Cohen 1,771,700 sh (-2.44%)
Jim Simons 136,111 sh (-59.06%)
» More
Q3 2016

WMGI Guru Trades in Q3 2016

Joel Greenblatt 28,955 sh (New)
Eaton Vance Worldwide Health Sciences Fund 1,009,222 sh (New)
Ken Fisher 2,593,555 sh (+6.07%)
Mario Gabelli 217,519 sh (unchged)
Keeley Asset Management Corp 1,318,524 sh (-13.54%)
Jim Simons 115,207 sh (-15.36%)
Steven Cohen 906,700 sh (-48.82%)
» More
Q4 2016

WMGI Guru Trades in Q4 2016

Mario Gabelli 217,519 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 1,009,222 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Ken Fisher 2,503,745 sh (-3.46%)
Keeley Asset Management Corp 1,199,691 sh (-9.01%)
Steven Cohen 127,300 sh (-85.96%)
» More
» Details

Insider Trades

Latest Guru Trades with WMGI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NYSE:NVRO, NYSE:GMED, NYSE:PEN, OTCPK:GGNDF, NAS:LIVN, NAS:IART, NAS:ZLTQ, OTCPK:EKTAY, OTCPK:FSPKF, OTCPK:NHNKY, NAS:MASI, NAS:NUVA, NAS:CYNO, NAS:INGN, OTCPK:IOBCF, NAS:BABY, NAS:CNMD, NAS:SPNC, NYSE:ITGR, NAS:VASC » details
Traded in other countries:T98.Germany,
Wright Medical Group NV a medical device company, designs, manufactures, markets, and sells orthopaedic products in the United States, France, and internationally. It offers joint implants & bone fixation devices for the shoulder, elbow, foot, and ankle.

Wright Medical Group NV was founded in the 1940s by René Tornier in Saint-Ismier, France. The Company is a medical device company focused on extremities and biologics products. It provides surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets. The Company has operations located in Memphis, Tennessee (U.S. headquarters, research and development, sales and marketing administration, and administrative activities); Bloomington, Minnesota (upper extremities sales and marketing); Arlington, Tennessee (manufacturing and warehousing operations); Grenoble, France (manufacturing and research and development); and Macroom, Ireland (manufacturing). In addition, it has local sales and distribution offices in Canada, Australia, Asia, and throughout Europe. The Company operates in one segment, orthopaedic products, which includes the design, manufacture, marketing, and sales of extremities and biologics products. It offers product portfolio of over 160 extremities products and 20 biologics products that are designed to provide solutions to its surgeon customers. Its product portfolio consists of Upper extremities, which include joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which include joint implants and bone fixation devices for the foot and ankle; Biologics, which include products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth; Sports medicine and other, which include products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products; and Large joints, which include hip and knee replacement implants. Its sales and marketing efforts are engaged in orthopaedic, trauma, and podiatric surgeons. The Company's sales and distribution system in the United States consisted of 65 geographic sales territories that are staffed by 458 direct sales representatives and 30 independent sales agencies or distributors. Internationally, it sells its full product portfolio, including products for upper and lower extremities, biologics, sports medicine and other, and large joints. Its international sales and distribution system currently consists of 11 direct sales offices and approximately 90 distributors that sell products in over 50 countries. It has subsidiaries with direct sales offices in the United Kingdom, France, Germany, Italy, Denmark, Netherlands, Canada, Japan, and Australia. Its products are sold in other countries in Europe, Asia, Africa, and Latin America using stocking distribution partners. The Company manufactures its internally-sourced products in four locations: Arlington, Tennessee; Montbonnot, France; Grenoble, France; and Macroom, Ireland. It leases the manufacturing facility in Arlington, Tennessee from the Industrial Development Board of the Town of Arlington. The Com

Guru Investment Theses on Wright Medical Group NV

Keeley Asset Management Comments on Wright Medical Group - Oct 21, 2016

One of the Fund’s main drivers this quarter was Wright Medical Group (NASDAQ:WMGI), which gained nearly 40% and contributed 141 basis points in performance. The company provides surgical solutions for the foot and ankle market and its products include joint implants for hip and knee replacements. The company reported a strong second quarter and raised guidance, proving the benefit of the Tornier acquisition.



From Keeley All Cap Value Fund third-quarter 2016 commentary.



Check out Keeley Asset Management Corp latest stock trades

John Keeley Comments on Wright Medical Group - Apr 26, 2016

Health Care proved to be challenging this quarter and our leading detractors all came from this sector. Despite a positive quarter and the completion of a recent European based acquisition, Wright Medical Group (NASDAQ:WMGI) stock was pressured on fears of potential litigation involving metal to metal hip implants, which could exceed the company’s liability insurance. Other orthopedic companies have suffered from similar legal disputes involving alleged, early device failure in recent years. A judgement was recently handed down on its first case with 80% less in damages awarded than had been initially estimated. Regardless of what appears to be a favorable outcome, WMGI plans to appeal the case and ultimately hopes to certify and settle the class of claims well within its liability insurance limits. We believe WMGI will ultimately prevail on this issue and the stock remains attractive.



From Keeley All Cap Value Fund first quarter 2016 commentary.



Check out John Keeley latest stock trades

Top Ranked Articles about Wright Medical Group NV

Keeley Asset Management Comments on Wright Medical Group Guru stock highlight
One of the Fund’s main drivers this quarter was Wright Medical Group (NASDAQ:WMGI), which gained nearly 40% and contributed 141 basis points in performance. The company provides surgical solutions for the foot and ankle market and its products include joint implants for hip and knee replacements. The company reported a strong second quarter and raised guidance, proving the benefit of the Tornier acquisition. Read more...
John Keeley Comments on Wright Medical Group Guru stock highlight
Health Care proved to be challenging this quarter and our leading detractors all came from this sector. Despite a positive quarter and the completion of a recent European based acquisition, Wright Medical Group (NASDAQ:WMGI) stock was pressured on fears of potential litigation involving metal to metal hip implants, which could exceed the company’s liability insurance. Other orthopedic companies have suffered from similar legal disputes involving alleged, early device failure in recent years. A judgement was recently handed down on its first case with 80% less in damages awarded than had been initially estimated. Regardless of what appears to be a favorable outcome, WMGI plans to appeal the case and ultimately hopes to certify and settle the class of claims well within its liability insurance limits. We believe WMGI will ultimately prevail on this issue and the stock remains attractive. Read more...

Ratios

vs
industry
vs
history
P/B 3.88
WMGI's P/B is ranked lower than
56% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. WMGI: 3.88 )
Ranked among companies with meaningful P/B only.
WMGI' s P/B Range Over the Past 10 Years
Min: 1.47  Med: 2.06 Max: 4.84
Current: 3.88
1.47
4.84
P/S 3.63
WMGI's P/S is ranked lower than
53% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 3.29 vs. WMGI: 3.63 )
Ranked among companies with meaningful P/S only.
WMGI' s P/S Range Over the Past 10 Years
Min: 2.14  Med: 3.12 Max: 5.08
Current: 3.63
2.14
5.08
Current Ratio 1.71
WMGI's Current Ratio is ranked lower than
70% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. WMGI: 1.71 )
Ranked among companies with meaningful Current Ratio only.
WMGI' s Current Ratio Range Over the Past 10 Years
Min: 1.71  Med: 2.65 Max: 3.29
Current: 1.71
1.71
3.29
Quick Ratio 1.32
WMGI's Quick Ratio is ranked lower than
66% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. WMGI: 1.32 )
Ranked among companies with meaningful Quick Ratio only.
WMGI' s Quick Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.59 Max: 1.99
Current: 1.32
1.18
1.99
Days Inventory 310.74
WMGI's Days Inventory is ranked lower than
85% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 130.88 vs. WMGI: 310.74 )
Ranked among companies with meaningful Days Inventory only.
WMGI' s Days Inventory Range Over the Past 10 Years
Min: 310.74  Med: 432.62 Max: 530.83
Current: 310.74
310.74
530.83
Days Sales Outstanding 64.80
WMGI's Days Sales Outstanding is ranked higher than
53% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 66.78 vs. WMGI: 64.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
WMGI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.15  Med: 72.28 Max: 115.13
Current: 64.8
64.15
115.13
Days Payable 45.29
WMGI's Days Payable is ranked lower than
61% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. WMGI: 45.29 )
Ranked among companies with meaningful Days Payable only.
WMGI' s Days Payable Range Over the Past 10 Years
Min: 45.29  Med: 84.7 Max: 156.08
Current: 45.29
45.29
156.08

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -35.00
WMGI's 3-Year Average Share Buyback Ratio is ranked lower than
88% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. WMGI: -35.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WMGI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -35  Med: -19.6 Max: -7.6
Current: -35
-35
-7.6

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.17
WMGI's Price/Median PS Value is ranked lower than
62% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. WMGI: 1.17 )
Ranked among companies with meaningful Price/Median PS Value only.
WMGI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.71  Med: 1.05 Max: 1.47
Current: 1.17
0.71
1.47
Earnings Yield (Greenblatt) (%) -5.51
WMGI's Earnings Yield (Greenblatt) (%) is ranked lower than
61% of the 337 Companies
in the Global Medical Devices industry.

( Industry Median: -0.30 vs. WMGI: -5.51 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WMGI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -10.27  Med: 3.1 Max: 8.9
Current: -5.51
-10.27
8.9

More Statistics

Revenue (TTM) (Mil) $686.0
EPS (TTM) $ -4.71
Beta1.19
Short Percentage of Float16.79%
52-Week Range $15.52 - 27.09
Shares Outstanding (Mil)103.31

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 680 754 853
EPS ($) -0.54 -0.23 0.08
EPS w/o NRI ($) -0.54 -0.23 0.08
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for WMGI

Headlines

Articles On GuruFocus.com
Keeley Asset Management Comments on Wright Medical Group Oct 21 2016 
KEELEY All Cap Value Fund 3rd Quarter Commentary Oct 21 2016 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
John Keeley Comments on Wright Medical Group Apr 26 2016 

More From Other Websites
Wright Pops To Nearly 6-Year High On Strong Q4 Results, 2017 Outlook Feb 22 2017
Wright Medical (WMGI) Posts Narrower-than-Expected Q4 Loss Feb 22 2017
Edited Transcript of WMGI earnings conference call or presentation 21-Feb-17 9:30pm GMT Feb 22 2017
Wright Medical reports 4Q loss Feb 21 2017
Wright Medical reports 4Q loss Feb 21 2017
Wright Medical Group NV Earnings Call scheduled for 4:30 pm ET today Feb 21 2017
4:22 pm Wright Medical Group beats by $0.05, beats on revs; guides FY17 EPS below consensus, revs... Feb 21 2017
WRIGHT MEDICAL GROUP N.V. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 21 2017
Wright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides... Feb 21 2017
Q4 2016 Wright Medical Group NV Earnings Release - 4:00 pm ET Feb 21 2017
MedTech Stocks Earnings Slated on Feb 21: MDT, HSIC and More Feb 20 2017
Wright Medical Group downgraded by Needham Feb 15 2017
Can Wright Medical (WMGI) Surprise Investors in Q4 Earnings? Feb 14 2017
Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors Feb 14 2017
Wright Medical Group N.V. to Host Fourth Quarter 2016 Earnings Conference Call Jan 31 2017
Wright Medical Group NV breached its 50 day moving average in a Bullish Manner : WMGI-US : January... Jan 06 2017
WRIGHT MEDICAL GROUP N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Dec 29 2016
Wright Medical Group NV breached its 50 day moving average in a Bullish Manner : WMGI-US : December... Dec 27 2016
Wright Medical Group NV – Value Analysis (NASDAQ:WMGI) : December 19, 2016 Dec 19 2016
Wright Medical Group NV breached its 50 day moving average in a Bearish Manner : WMGI-US : December... Dec 16 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)